This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Lao TD, Le TAH. MicroRNAs: Biogenesis, functions and potential biomarkers for early screening, prognosis and therapeutic molecular monitoring of nasopharyngeal carcinoma. Processes. 2020; 8(8): 966-1009.LaoTDLeTAHMicroRNAs: Biogenesis, functions and potential biomarkers for early screening, prognosis and therapeutic molecular monitoring of nasopharyngeal carcinoma202088966100910.3390/pr8080966Search in Google Scholar
Tabuchi K, Nakayama M, Nishimura B, Hayashi K, Hara A. Early detection of nasopharyngeal carcinoma. Int J Otolaryngol. 2011; 2011: 638058.TabuchiKNakayamaMNishimuraBHayashiKHaraAEarly detection of nasopharyngeal carcinoma2011201163805810.1155/2011/638058Search in Google Scholar
Li M, Wang C, Yu B, Zhang X, Shi F, Liu X. Diagnostic value of RASSF1A methylation for breast cancer: A meta-analysis. Biosci Rep. 2019; 39(6): BSR20190923.LiMWangCYuBZhangXShiFLiuXDiagnostic value of RASSF1A methylation for breast cancer: A meta-analysis2019396BSR2019092310.1042/BSR20190923Search in Google Scholar
Rowe M, Lear AL, Croom-Carter D, Davies AH, Rickinson AB. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol. 1992; 66(1): 122-131.RoweMLearALCroom-CarterDDaviesAHRickinsonABThree pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes199266112213110.1128/jvi.66.1.122-131.1992Search in Google Scholar
Vera-Sempere FJ, Burgos JS, Botella MS, Cordoba J, Gobernado M. Immunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients. Eur J Cancer B Oral Oncol. 1996; 32B(3): 163-168.Vera-SempereFJBurgosJSBotellaMSCordobaJGobernadoMImmunohistochemical expression of Epstein-Barr virus-encoded latent membrane protein (LMP-1) in paraffin sections of EBV-associated nasopharyngeal carcinoma in Spanish patients199632B3163–16810.1016/0964-1955(95)00093-3Search in Google Scholar
Young LS, Dawson CW, Eliopoulos AG. The expression and function of Epstein-Barr virus encoded latent genes. Mol Pathol. 2000; 53(5): 238-247.YoungLSDawsonCWEliopoulosAGThe expression and function of Epstein-Barr virus encoded latent genes200053523824710.1136/mp.53.5.238118697611091847Search in Google Scholar
Lao TD, Nguyen DH, Nguyen TM, Le TAH. Molecular screening for Epstein-Barr virus (EBV): Detection of genomic EBNA-1, EBNA-2, LMP-1, LMP-2 among Vietnamese patients with nasopharyngeal brush samples. Asian Pac J Cancer Prev. 2017; 18(6): 1675-1679.LaoTDNguyenDHNguyenTMLeTAHMolecular screening for Epstein-Barr virus (EBV): Detection of genomic EBNA-1, EBNA-2, LMP-1, LMP-2 among Vietnamese patients with nasopharyngeal brush samples201718616751679Search in Google Scholar
Lao TD, Nguyen TAH, Ngo KD, Thieu HH, Nguyen MT, Nguyen DH, et al. Molecular screening of nasopharyngeal carcinoma: Detection of LMP-1, LMP-2 gene expression in Vietnamese nasopharyngeal swab samples. Asian Pac J Cancer Prev. 2019; 20(9): 27572761.LaoTDNguyenTAHNgoKDThieuHHNguyenMTNguyenDHet alMolecular screening of nasopharyngeal carcinoma: Detection of LMP-1, LMP-2 gene expression in Vietnamese nasopharyngeal swab samples20192092757276110.31557/APJCP.2019.20.9.2757697683031554374Search in Google Scholar
Pathmanathan R, Prasad U, Sadler R, Flynn K, Raab-Traub N. Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med. 1995; 333(11): 693-698.PathmanathanRPrasadUSadlerRFlynnKRaab-TraubNClonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma19953331169369810.1056/NEJM1995091433311037637746Search in Google Scholar
Raab-Traub N. Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol. 2002; 12(6): 431-441.Raab-TraubNEpstein-Barr virus in the pathogenesis of NPC200212643144110.1016/S1044579X0200086XSearch in Google Scholar
Zhao Y, Wang Y, Zeng S, Hu X. LMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis. J Clin Pathol. 2012; 65(1): 41-45.ZhaoYWangYZengSHuXLMP1 expression is positively associated with metastasis of nasopharyngeal carcinoma: evidence from a meta-analysis2012651414510.1136/jclinpath-2011-20019822039283Search in Google Scholar
Goodwin M, Yap AS. Classical cadherin adhesion molecules: Coordinating cell adhesion, signaling and the cytoskeleton. J Mol Histol. 2004; 35(9): 839-844.GoodwinMYapASClassical cadherin adhesion molecules: Coordinating cell adhesion, signaling and the cytoskeleton200435983984410.1007/s10735-004-1833-2Search in Google Scholar
Jeanes A, Gottardi CJ, Yap AS. Cadherins and cancer: How does cadherin dysfunction promote tumor progression? Oncogene. 2008; 27(55): 6920-6929.JeanesAGottardiCJYapASCadherins and cancer: How does cadherin dysfunction promote tumor progression?200827556920692910.1038/onc.2008.343Search in Google Scholar
Tsao SW, Liu Y, Wang XX, Yuen PW, Leung SY, Yuen ST, et al. The association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells. Eur J Cancer. 2003; 39(4): 524-531.TsaoSWLiuYWangXXYuenPWLeungSYYuenSTet alThe association of E-cadherin expression and the methylation status of the E-cadherin gene in nasopharyngeal carcinoma cells200339452453110.1016/S0959-8049(02)00494-XSearch in Google Scholar
Niemhom S, Kitazawa S, Kitazawa R, Maeda S, Leopairat J. Hypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma. Cancer Detect Prev. 2008; 32(2): 127-134.NiemhomSKitazawaSKitazawaRMaedaSLeopairatJHypermethylation of epithelial-cadherin gene promoter is associated with Epstein-Barr virus in nasopharyngeal carcinoma200832212713410.1016/j.cdp.2008.05.005Search in Google Scholar
Ayadi W, Karray-Hakim H, Khabir A, Feki L, Charfi S, Boudawara T, et al. Aberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients. Anticancer Res. 2008; 28(4B): 2161-2167.AyadiWKarray-HakimHKhabirAFekiLCharfiSBoudawaraTet alAberrant methylation of p16, DLEC1, BLU and E-cadherin gene promoters in nasopharyngeal carcinoma biopsies from Tunisian patients2008284B21612167Search in Google Scholar
Ran Y, Wu S, You Y. Demethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy. J Biochem. 2011; 149(1): 49-54.RanYWuSYouYDemethylation of E-cadherin gene in nasopharyngeal carcinoma could serve as a potential therapeutic strategy20111491495410.1093/jb/mvq128Search in Google Scholar
Ryan JL, Fan H, Glazer SL, Schichman SA, Raab-Traub N, Gulley ML. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segment: A novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn. 2004; 6(4): 378-385.RyanJLFanHGlazerSLSchichmanSARaab-TraubNGulleyMLEpstein-Barr virus quantitation by real-time PCR targeting multiple gene segment: A novel approach to screen for the virus in paraffin-embedded tissue and plasma20046437838510.1016/S1525-1578(10)60535-1Search in Google Scholar
Al-Mozaini M, Bodelon G, Karsstegl CE, Jin B, Al-Ahdal M, Farrell PJ. Epstein-Barr virus BART gene expression. J Gen Virol. 2009; 90(Pt 2): 307-316.Al-MozainiMBodelonGKarssteglCEJinBAl-AhdalMFarrellPJEpstein-Barr virus BART gene expression200990Pt 230731610.1099/vir.0.006551-019141439Search in Google Scholar
Banko A, Lazarevic I, Cupic M, Stevanovic G, Boricic I, Jovanovic T. Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients. J Med Virol. 2012; 84(4): 632-642.BankoALazarevicICupicMStevanovicGBoricicIJovanovicTCarboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients201284463264210.1002/jmv.2321722337303Search in Google Scholar
Dawson CW, Port RJ, Young LS. The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol. 2012; 22(2): 144-153.DawsonCWPortRJYoungLSThe role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)201222214415310.1016/j.semcancer.2012.01.00422249143Search in Google Scholar
Hao SP, Tsang NM, Chang KP, Ueng SH. Molecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab. Otolaryngol Head Neck Surg. 2004; 131(5): 651-654.HaoSPTsangNMChangKPUengSHMolecular diagnosis of nasopharyngeal carcinoma: Detecting LMP-1 and EBNA by nasopharyngeal swab2004131565165410.1016/j.otohns.2004.04.01315523443Search in Google Scholar
See HS, Yap YY, Yip WK, Seow HF. Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol. 2008; 6: 18-27.SeeHSYapYYYipWKSeowHFEpstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia20086182710.1186/1477-7819-6-18226571618275617Search in Google Scholar
Kang MS, Kieff E. Epstein-Barr virus latent genes. Exp Mol Med. 2015; 47(1): e131-e146.KangMSKieffEEpstein-Barr virus latent genes2015471e131e14610.1038/emm.2014.84431458325613728Search in Google Scholar
Li Z, Lin SX, Liang YJ. Influence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells. Zhonghua Zhong Liu Za Zhi. 2003; 25(3): 238-242.LiZLinSXLiangYJInfluence of E-cadherin promoter methylation and mutation of beta-catenin on invasion and metastasis of nasopharyngeal carcinoma cells2003253238242Search in Google Scholar
Palmisano WA, Divine KK, Saccomanno G, Gilliland FD, Baylin SB, Herman JG, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60(21): 5954-5958.PalmisanoWADivineKKSaccomannoGGillilandFDBaylinSBHermanJGet alPredicting lung cancer by detecting aberrant promoter methylation in sputum2000602159545958Search in Google Scholar
Lin SX, Zong YS, Chu B, Zhong BL, Li Z, Liang YJ, et al. Relationship between the expressions of LMP-1 and e-cadherin/beta-catenin in nasopharyngeal carcinoma. Chin J Cancer Res. 2002; 14(3): 202-205.LinSXZongYSChuBZhongBLLiZLiangYJet alRelationship between the expressions of LMP-1 and e-cadherin/beta-catenin in nasopharyngeal carcinoma200214320220510.1007/s11670-002-0045-0Search in Google Scholar
Qiu X, Qiao F, Su X, Zhao Z, Fan H. Epigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma. Exp Ther Med. 2010; 1(3): 519-523.QiuXQiaoFSuXZhaoZFanHEpigenetic activation of E-cadherin is a candidate therapeutic target in human hepatocellular carcinoma20101351952310.3892/etm_00000082344593322993570Search in Google Scholar
Corso G, Bonanni B, Veronesi P. Tumor inactivation of E-cadherin: A new tool for breast cancer treatment? Ann Transl Med. 2018; 6(Suppl 1): S6.CorsoGBonanniBVeronesiPTumor inactivation of E-cadherin: A new tool for breast cancer treatment?20186Suppl 1S610.21037/atm.2018.08.45629160130613582Search in Google Scholar
Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy. Oncogene. 2002; 21(35): 5483-5495.ChristmanJK5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: Mechanistic studies and their implications for cancer therapy200221355483549510.1038/sj.onc.120569912154409Search in Google Scholar
Nam JS, Ino Y, Kanai Y, Sakamoto M, Hirohashi S. 5-Aza-2’-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis. Clin Exp Metastasis. 2004; 21(1): 49-56.NamJSInoYKanaiYSakamotoMHirohashiS5-Aza-2’-deoxycytidine restores the E-cadherin system in E-cadherin-silenced cancer cells and reduces cancer metastasis2004211495610.1023/B:CLIN.0000017180.19881.c1Search in Google Scholar
Hannigan A, Wilson JB. Evaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition. Mol Cancer. 2010; 9: 184.HanniganAWilsonJBEvaluation of LMP1 of Epstein-Barr virus as a therapeutic target by its inhibition2010918410.1186/1476-4598-9-184291398420618963Search in Google Scholar